Form D · Other Health Care
AccuVein Inc.
Medford, NY · CIK 0001526868
Offering snapshot reported Feb 10, 2023 · SEC filing
- Reported sold
- $5.31M Offering amount: $5.4M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,097,814 → $5,306,083
- Reported investors20 → 25
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2023 | Amendment | $5,306,083 | $2,208,269vs Feb 10, 2023 | 25 | SEC filing |
| Feb 10, 2023 | Initial | $3,097,814 | No comparison | 20 | SEC filing |
| Apr 8, 2022 | Amendment | $17,296,753 | $3,503,229vs Oct 28, 2020 | 36 | SEC filing |
| Oct 28, 2020 | Amendment | $13,793,524 | $8,409,920vs Sep 8, 2020 | 36 | SEC filing |
| Sep 8, 2020 | Initial | $5,383,604 | No comparison | 4 | SEC filing |
| May 12, 2020 | Initial | $2,547,338 | No comparison | 33 | SEC filing |
| Nov 15, 2019 | Initial | $2,000,018 | No comparison | 33 | SEC filing |
| Feb 12, 2018 | Initial | $8,000,000 | No comparison | 40 | SEC filing |
| Jan 2, 2018 | Amendment | $2,900,846 | $1,500,846vs Nov 13, 2017 | 11 | SEC filing |
| Nov 13, 2017 | Initial | $1,400,000 | No comparison | 6 | SEC filing |
| Dec 2, 2016 | Initial | $2,455,008 | No comparison | 28 | SEC filing |
| Oct 27, 2011 | Amendment | $23,461,510 | $500,000vs Aug 2, 2011 | 62 | SEC filing |
| Aug 2, 2011 | Initial | $22,961,510 | No comparison | 59 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-473238
Source: Form D, filed Feb 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Bednarski | Director |
| Frank Flaunt Iii | Director |
| Frank Flaut Iii | Director |
| Frank Lee Flautt Iii | Director |
| Christopher Gabrieli | Director |
| Ron Goldman | Director, Executive |
| Hugo Harrod | Director |
| Christopher Hutchison | Director, Executive |
| Chuck Johnson | Executive |
| James Lackie | Director |
| Vincent Luciano | Executive |
| Rudy Mazzochi | Director |
| Kevin Mc Ardle | Executive |
| Joseph Mc Cormick | Executive |
| Akhilesh Pathipati | Director |
| Stephen Reeders | Director |
| Heather Rohan | Director |
| Brian Verrier | Director |
| Joseph Anthony Zott | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3243 Route 112, Building 1, Suite 2
Medford, NY, 11763
Medford, NY, 11763